The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Aberrant Activation of Focal Adhesion Proteins Mediates Fibrillar Amyloid β-Induced Neuronal Dystrophy
Open accessAbstract
Neuronal dystrophy is a pathological hallmark of Alzheimer's disease (AD) that is not observed in other neurodegenerative disorders that lack amyloid deposition. Treatment of cortical neurons with fibrillar amyloid beta (Abeta) peptides induces progressive neuritic dystrophy accompanied by a marked loss of synaptophysin immunoreactivity (Grace et al., 2002). Here, we report that fibrillar Abeta-induced neuronal dystrophy is mediated by the activation of focal adhesion (FA) proteins and the formation of aberrant FA structures adjacent to Abeta deposits. In the AD brain, activated FA proteins are observed associated with the majority of senile plaques. Clustered integrin receptors and activated paxillin (phosphorylated at Tyr-31) and focal adhesion kinase (phosphorylated at Tyr-297) are mainly detected in dystrophic neurites surrounding Abeta plaque cores, where they colocalize with hyperphosphorylated tau. Deletion experiments demonstrated that the presence of the LIM domains in the paxillin C terminus and the recruitment of the protein-Tyr phosphatase (PTP)-PEST to the FA complex are required for Abeta-induced neuronal dystrophy. Therefore, both paxillin and PTP-PEST appear to be critical elements in the generation of the dystrophic response. Paxillin is a scaffolding protein to which other FA proteins bind, leading to the formation of the FA contact and initiation of signaling cascades. PTP-PEST plays a key role in the dynamic regulation of focal adhesion contacts in response to extracellular cues. Thus, in the AD brain, fibrillar Abeta may induce neuronal dystrophy by triggering a maladaptive plastic response mediated by FA protein activation and tau hyperphosphorylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Together, these results implicate the integrin–cofilin pathway to be critical in synaptic dysfunction in AD [36, 147].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [36]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For instance, dynamic FAK signaling is commonly seen sur rounding Aβ plaques in human AD patients (Grace and Busciglio, 2003; Saleh et al., 2022)”
From Alzheimer’s genetic risk factor CASS4 controls microglial focal adhesion biology and amyloidosis (2026) · cites this paper as Grace and Busciglio, 2003
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, previous work has uncovered that multiple canonical focal ad hesion signaling molecules are actively engaged in the AD brain.”
From Alzheimer’s genetic risk factor CASS4 controls microglial focal adhesion biology and amyloidosis (2026) · cites this paper as Grace and Busciglio, 2003
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, focal adhesion signaling has re cently been linked to AD through both genetic risk factors and Aβ-associated signaling events (Grace and Busciglio, 2003; Lambert et al., 2013; Lin et al., 2017; Manocha et al., 2015; Ramos de Matos et al., 2018; Saleh et al., 2022; Schwartzentruber et al., 2021; Wang et al., 2015b)”
From Alzheimer’s genetic risk factor CASS4 controls microglial focal adhesion biology and amyloidosis (2026) · cites this paper as Grace and Busciglio, 2003
The cited source says what the claim attributes to it.
In the citing paper
“In addition, aberrant activation of the FA pathway may mediate Aβ fibril-induced neuronal dystrophy [36].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Taking Cell-Matrix Adhesions to the Third Dimension
Cukierman, E., Pankov, R., Stevens, D. R., & Yamada, K. M. (2001) · Science · doi:10.1126/science.1064829 · Cited by 3,027
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Mattson, M. P., Cheng, B., Davis, D. G., Bryant, K., Lieberburg, I. M., & Rydel, R. E. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,633
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Amyloid pores from pathogenic mutations
Lashuel, H. A., Hartley, D. M., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,307
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 953
Aplin, A. E., Howe, A. K., Alahari, S. K., & Juliano, R. L. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01359-0 · Cited by 858
Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
Busciglio, J., & Yankner, B. A. (1995) · Nature · doi:10.1038/378776a0 · Cited by 741
Self-citation
Cited by
Sorted by citations
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Cruz, J. C., Tseng, H.-C., Goldman, J. A., Shih, H., & Tsai, L.-H. (2003) · Neuron · doi:10.1016/s0896-6273(03)00627-5 · Cited by 609
Deshpande, A. M., Mina, E. W., Glabe, C. G., & Busciglio, J. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1189-06.2006 · Cited by 508
Self-citationApoE4 Accelerates Early Seeding of Amyloid Pathology
Liu, C.-C., Zhao, N., Fu, Y., Wang, N., Linares, C., Tsai, C.-W., & Bu, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.11.013 · Cited by 451
Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
De Felice, F. G., Wu, D., Lambert, M. P., Fernandez, S. J., Velasco, P. T., Lacor, P. N., Bigio, E. H., Jerecic, J., Acton, P. J., Shughrue, P. J., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.029 · Cited by 432
Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease
Lee, G. S., Thangavel, R., Sharma, V. M., Litersky, J. M., Bhaskar, K., Fang, S. M., Lana, H., Andreadis, A., Hoesen, G. W. V., & Ksiȩżak-Reding, H. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4162-03.2004 · Cited by 435
Glycogen synthase kinase 3: a drug target for CNS therapies
Bhat, R. V., Haeberlein, S. L. B., & Ávila, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02422.x · Cited by 415
Neuritic regeneration and synaptic reconstruction induced by withanolide A
Kuboyama, T., Tohda, C., & Komatsu, K. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706122 · Cited by 339
Gupta, A., Bisht, B., & Dey, C. S. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.033 · Cited by 302
Alzheimer's Presenilin 1 Mutations Impair Kinesin-Based Axonal Transport
Pigino, G. F., Morfini, G. A., Pelsman, A., Mattson, M. P., Brady, S. T., & Busciglio, J. A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04499.2003 · Cited by 303
Self-citationDesai, M. K., Sudol, K. L., Janelsins, M. C., Mastrangelo, M. A., Frazer, M. E., & Bowers, W. J. (2009) · Glia · doi:10.1002/glia.20734 · Cited by 266
The significance of neuroinflammation in understanding Alzheimer’s disease
Eikelenboom, P., Veerhuis, R., Scheper, W., Rozemüller, A. J. M., van Gool, W. A., & Hoozemans, J. J. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0575-6 · Cited by 268
Verdier, Y., Zarándi, M., & Penke, B. (2004) · Journal of Peptide Science · doi:10.1002/psc.573 · Cited by 267
Tom, V. J., Steinmetz, M. P., Miller, J. H., Doller, C. M., & Silver, J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0994-04.2004 · Cited by 264
Search for natural products related to regeneration of the neuronal network
Tohda, C., Kuboyama, T., & Komatsu, K. (2005) · Neurosignals · doi:10.1159/000085384 · Cited by 257
Resende, R., Ferreiro, E., Pereira, C., & Resende de Oliveira, C. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.036 · Cited by 235
Fyn kinase inhibition as a novel therapy for Alzheimer’s disease
Nygaard, H. B., van Dyck, C. H., & Strittmatter, S. M. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt238 · Cited by 206
Heredia, L., Helguera, P. R., de Olmos, S., Kedikian, G., Vigo, F. S., LaFerla, F. M., Staufenbiel, M., de Olmos, J. S., Busciglio, J. A., Cáceres, A., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5567-05.2006 · Cited by 184
Self-citationCytoskeletal pathologies of Alzheimer disease
Bamburg, J. R., & Bloom, G. S. (2009) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20388 · Cited by 175
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology
Hoozemans, J. J. M., Veerhuis, R., Rozemüller, A. J. M., & Eikelenboom, P. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.001 · Cited by 171
Dourlen, P., Kilinc, D., Malmanche, N., Chapuis, J., & Lambert, J.-C. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02004-0 · Cited by 168
Targeting Fyn Kinase in Alzheimer’s Disease
Nygaard, H. B. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.004 · Cited by 162
Chin, J., Palop, J. J., Yu, G.-Q., Kojima, N., Masliah, E., & Mucke, L. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0277-04.2004 · Cited by 162
Synaptic memory mechanisms: Alzheimer's disease amyloid β-peptide-induced dysfunction
Rowan, M. J., Klyubin, I. V., Wang, Q., Hu, N., & Anwyl, R. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351219 · Cited by 154
Neiiendam, J. L., Køhler, L. B., Christensen, C., Li, S., Pedersen, M. V., Ditlevsen, D. K., Kornum, M. K., Kiselyov, V. V., Berezin, V., & Bock, E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02779.x · Cited by 150
Tohda, C., Matsumoto, N., Zou, K., Meselhy, M. R., & Komatsu, K. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300388 · Cited by 142
Site-Specific Blockade of RAGE-VdPrevents Amyloid-β Oligomer Neurotoxicity
Sturchler, E., Galichet, A., Weibel, M., Leclerc, E., & Heizmann, C. W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4878-07.2008 · Cited by 136
Gupta, A. K., & Dey, C. S. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-05-0337 · Cited by 119
Dourlen, P., Fernandez-Gomez, F. J., Dupont, C., Grenier-Boley, B., Bellenguez, C., Obriot, H., Caillierez, R., Sottejeau, Y., Chapuis, J., Bretteville, A., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.59 · Cited by 118
Tohda, C., Tamura, T., Matsuyama, S., & Komatsu, K. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706865 · Cited by 116
Cofilin-mediated neurodegeneration in alzheimer’s disease and other amyloidopathies
Maloney, M. T., & Bamburg, J. R. (2007) · Molecular Neurobiology · doi:10.1007/bf02700622 · Cited by 115
Tau and src family tyrosine kinases
Lee, G. S. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.002 · Cited by 111
Focal adhesions regulate Aβ signaling and cell death in Alzheimer's disease
Caltagarone, J., Jing, Z., & Bowser, R. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.11.007 · Cited by 102
Pfundstein, G., Nikonenko, A. G., & Sytnyk, V. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.969547 · Cited by 89
PathNet: a tool for pathway analysis using topological information
Dutta, B., Wallqvist, A., & Jaques Reifman, A. (2012) · Source Code for Biology and Medicine · doi:10.1186/1751-0473-7-10 · Cited by 81
Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice
Dickey, C. A., Gordon, M. N., Wilcock, D. M., Herber, D. L., Freeman, M. J., & Morgan, D. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-7 · Cited by 76
Godoy, J. A., Lindsay, C. B., Quintanilla, R. A., Carvajal, F. J., Cerpa, W. F., & Inestrosa, N. C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0203-x · Cited by 78
Tau impacts on growth-factor-stimulated actin remodeling
Sharma, V. M., Litersky, J. M., Bhaskar, K., & Lee, G. S. (2007) · Journal of Cell Science · doi:10.1242/jcs.03378 · Cited by 75
Datki, Z., Papp, R., Zádori, D., Soós, K., Fülöp, L., Juhász, A., Laskay, G., Hetényi, C., MIHALIK, E., & Zarándi, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.007 · Cited by 72
Astrocyte modulation of in vitro β‐amyloid neurotoxicity
Paradisi, S., Sacchetti, B., Balduzzi, M., Gaudi, S., & Malchiodi‐Albedi, F. (2004) · Glia · doi:10.1002/glia.20005 · Cited by 68
Bernstein, H., Bukowska, A., Krell, D., Bogerts, B., Ansorge, S., & Lendeckel, U. (2003) · Journal of Neurocytology · doi:10.1023/b:neur.0000005600.61844.a6 · Cited by 68
GVS‐111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons
Pelsman, A., Hoyo‐Vadillo, C., Гудашева, Т. А., Середенин, С. Б., Ostrovskaya, R. U., & Busciglio, J. A. (2003) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(03)00031-5 · Cited by 65
Self-citationNaito, R., & Tohda, C. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1892 · Cited by 61
Lachén‐Montes, M., González-Morales, A., de Morentin, X. M., Pérez‐Valderrama, E., Ausín, K., Zelaya, M. V., Serna, A., Aso, E., Ferrer, I., Fernández‐Irigoyen, J., et al. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.07.032 · Cited by 61
Roles of LIM kinases in central nervous system function and dysfunction
Cuberos, H., Vallée, B., Vourc'h, P., Tastet, J., Andres, C. R., & Bénédetti, H. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.10.032 · Cited by 54
Arora, H., Ramesh, M., Rajasekhar, K., & Govindaraju, T. (2020) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20190356 · Cited by 53
Garofalo, M., Pandini, C., Bordoni, M., Pansarasa, O., Rey, F., Costa, A. C., Minafra, B., Diamanti, L., Zucca, S., Carelli, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249500 · Cited by 54
Muresan, Z. L., & Mureşan, V. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0625 · Cited by 50
Bignante, E. A., Heredia, F., Morfini, G. A., & Lorenzo, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.021 · Cited by 50
Tohda, C., Nakada, R., Urano, T., Okonogi, A., & Kuboyama, T. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.602809 · Cited by 50
Periodontitis and alzheimer´s disease
Sansores‐España, L. D., Carrillo-Ávila, A., Melgar‐Rodríguez, S., Díaz‐Zúñiga, J., & Martínez-Aguilar, V. M. (2020) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.23940 · Cited by 53
Aβ Influences Cytoskeletal Signaling Cascades with Consequences to Alzheimer’s Disease
Henriques, A. G., Oliveira, J. M., Carvalho, L., & Silva, O. A. B. D. C. E. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8913-4 · Cited by 45
Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
Barbariga, M., Curnis, F., Andolfo, A., Zanardi, A., Lazzaro, M., Conti, A., Magnani, G., Volonté, M. A., Ferrari, L. D., Comı, G., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0055-2 · Cited by 47
Rao, K. V. R., Curtis, K. M., Johnstone, J. T., & Norenberg, M. D. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31829bd082 · Cited by 43
Amyloid-β precursor protein mediates neuronal toxicity of amyloid β through Go protein activation
Vigo, F. S., Kedikian, G., Heredia, L., Heredia, F., Añel, A. D., Rosa, A. L., & Lorenzo, A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.017 · Cited by 42
Non-receptor-tyrosine Kinases Integrate Fast Glucocorticoid Signaling in Hippocampal Neurons
Yang, S., Roselli, F., Patchev, A. V., Yu, S., & Almeida, O. F. X. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470146 · Cited by 40
Tau isoform expression and regulation in human cortical neurons
Deshpande, A. M., Win, K. M., & Busciglio, J. A. (2008) · The FASEB Journal · doi:10.1096/fj.07-096909 · Cited by 41
Self-citationLi, H., Yang, D., Ning, S., Xu, Y., Yang, F., Yin, R., Feng, T., Han, S., Guo, L., Zhang, P., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700418r · Cited by 37
Anderson, K. L., & Ferreira, A. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20018 · Cited by 37
Tohda, C., Naito, R., & Joyashiki, E. (2008) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-8-49 · Cited by 36
Xu, Z., Isaji, T., Fukuda, T., Wang, Y., & Gu, J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005923 · Cited by 36
Barbariga, M., Curnis, F., Spitaleri, A., Andolfo, A., Zucchelli, C., Lazzaro, M., Magnani, G., Musco, G., Corti, A., & Alessio, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.520981 · Cited by 35
The diverse roles and multiple forms of focal adhesion kinase in brain
Armendariz, B. G., Masdeu, M., Soriano, E., Ureña, J. M., & Burgaya, F. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12737 · Cited by 33
Integrins mediate β‐amyloid‐induced cell‐cycle activation and neuronal death
Frasca, G., Carbonaro, V., Merlo, S., Copani, A., & Sortino, M. A. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21487 · Cited by 33
Poulsen, E. T., Iannuzzi, F., Rasmussen, H. F., Maier, T. J., Enghild, J. J., Jørgensen, A. L., & Matrone, C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00059 · Cited by 31
RetractedFeuillette, S., Deramecourt, V., Laquerrière, A., Duyckaerts, C. J., Delisle, M., Maurage, C., Blum, D. L., Buée, L., Frébourg, T., Campion, D., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.007 · Cited by 34
Identification of synaptic plasma membrane proteins co‐precipitated with fibrillar β‐amyloid peptide
Verdier, Y., Huszár, E., Penke, B., Penke, Z., Woffendin, G., Ščigelová, M., Fülöp, L., Szűcs, M., Medzihradszky, K. F., & Janáky, T. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03158.x · Cited by 30
Protein phosphatase 5 protects neurons against amyloid‐β toxicity
Sanchez‐Ortiz, E., Hahm, B. K., Armstrong, D. L., & Rossie, S. S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06337.x · Cited by 29
Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies
Golde, T. E. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13583 · Cited by 29
Griffin, M. A., Feng, H., Tewari, M., Acosta, P., Kawana, M., Sweeney, H. L., & Discher, D. E. (2005) · Journal of Cell Science · doi:10.1242/jcs.01717 · Cited by 28
Tan, R.-Y., Xing, G., Zhou, G., Li, F., Hu, W., Lambein, F., Xiong, J., Zhang, S., Kong, H., Zhu, H., et al. (2017) · Scientific Reports · doi:10.1038/srep40677 · Cited by 25
Focal adhesion kinase negatively regulates neuronal insulin resistance
Gupta, A. K., Bisht, B., & Dey, C. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.011 · Cited by 27
Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid β precursor protein
Heredia, L., Lin, R., Vigo, F. S., Kedikian, G., Busciglio, J. A., & Lorenzo, A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.04.015 · Cited by 27
Self-citationAdvani, D., & Kumar, P. (2021) · ACS Omega · doi:10.1021/acsomega.1c01526 · Cited by 27
Acero, G., Manoutcharian, K., Vasilevko, V., Munguía, M. E., Govezensky, T., Coronas, G., Luz-Madrigal, A., Cribbs, D. H., & Gevorkian, G. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.06.003 · Cited by 26
Yeganeh, P. N., Kwak, S. S., Jorfi, M., Koler, K., Kalatturu, T., von Maydell, D. K., Liu, Z., Guo, K., Choi, Y., Park, J., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.10.029 · Cited by 24
Labour, M.-N., Vigier, S., Lerner, D. A., Marcilhac, A., & Belamie, E. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.04.001 · Cited by 22
Santana, D. A., Bedrat, A., Puga, R., Turecki, G., Mechawar, N., Faria, T. C., Gigek, C. O., Payão, S. L. M., Smith, M. D. A. C., Lemos, B., et al. (2022) · Epigenomics · doi:10.2217/epi-2022-0096 · Cited by 19
Caltagarone, J., Hamilton, R. L., MURDOCH, G. H., Zheng, J., DeFranco, D. B., & Bowser, R. P. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d53d98 · Cited by 21
Han, H.-Y., Zhang, J.-P., Ji, S.-Q., Liang, Q.-M., Kang, H.-C., Tang, R.-H., Zhu, S.-Q., & Xue, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064839 · Cited by 20
Morello, G., & Cavallaro, S. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.60 · Cited by 20
Construction of Quenchbodies to detect and image amyloid β oligomers
Dong, J., Fujita, R., Zako, T., & Ueda, H. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.04.016 · Cited by 20
An update on neuroimaging of multiple sclerosis
Matthews, P. M. (2004) · Current Opinion in Neurology · doi:10.1097/01.wco.0000137537.06986.b0 · Cited by 15
Identification of key lipid metabolism-related genes in Alzheimer’s disease
Zeng, Y., Cao, S., Li, N., Tang, J., & Lin, G. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01918-9 · Cited by 18
Xu, Y.-X., Wang, H.-Q., Yan, J., Sun, X.-B., Guo, J.-C., & Zhu, C.-Q. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.022 · Cited by 15
Ambjørn, M., Dubreuil, V., Miozzo, F., Nigon, F., Møller, B. K., Issazadeh‐Navikas, S., Berg, J., Lees, M. J., & Sap, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065371 · Cited by 15
Waseem, T. V., Lapatsina, L. P., & Fedorovich, S. V. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9585-5 · Cited by 14
Increased cell–cell adhesion, a novel effect of R-(−)-deprenyl
Jenei, V., Zór, K., Magyar, K., & Jakus, J. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0295-3 · Cited by 11
Saleh, B., Srikanth, K. D., Sneh, T., Yue, L., Pelech, S., Elliott, E., & Gil-Henn, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169055 · Cited by 10
Lain, E., Penke, B., Delacourte, A., Gündisch, D., Schröder, H., & Witter, B. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03909.x · Cited by 10
Neuronal insulin signaling and resistance: a balancing act of kinases and phosphatases
Sharma, M., Yadav, Y., & Dey, C. S. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0151 · Cited by 11
Barbariga, M., Zanardi, A., Curnis, F., Conti, A., Boselli, D., Terlizzi, S. D., & Alessio, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-72447-z · Cited by 10
Xia, W. R. (2015) · The Chinese Journal of Physiology · doi:10.4077/cjp.2015.bad273 · Cited by 8
Oligomerisation differentially affects the acute and chronic actions of amyloid-β in vitro
Innocent, N., Evans, N. A., Hille, C. J., & Wonnacott, S. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.003 · Cited by 7
Counts, S., Beck, J. S., Maloney, B., Malek‐Ahmadi, M. H., Ginsberg, S. D., Mufson, E. J., & Lahiri, D. K. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70019 · Cited by 6
The Role of Glycogen Synthase Kinase-3 (GSK-3) in Alzheimer’s Disease
Medina, M., & Avil, J. (2011) · InTech eBooks · doi:10.5772/16879 · Cited by 7
Verdier, Y., & Penke, B. (2006) · Current Signal Transduction Therapy · doi:10.2174/157436206775269208 · Cited by 6
Amyloid Hypothesis and Alzheimer's Disease
Sun, X., & Zhang, Y. (2011) · InTech eBooks · doi:10.5772/28947 · Cited by 4
Cofilin-mediated neurodegeneration in alzheimer’s disease and other amyloidopathies
Maloney, M. T., & Bamburg, J. R. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0009-y · Cited by 4
Reversible Photoregulation of Cell–Cell Adhesions With Opto-E-cadherin
Raab, C. A., & Wegner, S. V. (2024) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4995 · Cited by 2
Metadata
- Authors
- Grace, E. A., & Busciglio, J.
- Affiliations
- UConn Health (US)
- ORCID
- Busciglio, Jorge
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2003-01-15
- Volume
- 23
- Issue
- 2
- Pages
- 493-502
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6741895
- OpenAlex
- W1562586507
- Cited by
- 113
- References
- 81
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 5 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 7 · 2012: 4
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- University of Connecticut
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-38466, R01HD038466)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, fibrillar amyloid-beta, neuronal dystrophy, focal adhesion proteins, paxillin, PTP-PEST, focal adhesion kinase, integrins, tau hyperphosphorylation, synaptophysin, LIM domain, amyloid plaques, synaptic dysfunction, maladaptive plasticity
- MeSH terms
- Alzheimer Disease, Animals, Cells, Cultured, Cytoskeletal Proteins, Cytoskeleton, Luminescent Proteins, Neurons, Phosphoproteins, Phosphorylation, Recombinant Fusion Proteins, Transfection, Signal Transduction, Cell Adhesion Molecules, Integrins, Amyloid beta-Peptides, Neurites, tau Proteins, Cell Death, Protein Tyrosine Phosphatases, Protein Structure, Tertiary, Protein Transport, Focal Adhesions, Macromolecular Substances, Green Fluorescent Proteins, Rats, Paxillin, Protein Tyrosine Phosphatase, Non-Receptor Type 12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review